PRCT

Companies
NASDAQ
Procept BioRobotics Corporation
Health Care
Price Chart
Overview

About PRCT

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.

Market Cap
$3.5B
Volume
49.0M
Avg. Volume
63.9M
P/E Ratio
-44.105263
Dividend Yield
0.81%
Employees
493.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Medical Devices
Risk & Correlation Analysis
Market Correlation
0.84
Moderate Correlation
Volatility
High (0.64)
Relative to market

Macro Factor Sensitivities

Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for PRCT.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, PRCT shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$3.5B
Volume49.0M
P/E Ratio-44.11
Dividend Yield0.81%
Important Dates
Next Dividend
Next Earnings
April 24, 2025

PortfolioPilot Analysis

Get AI-powered insights on how PRCT fits into your investment strategy and portfolio diversification.

Pricing info last updated June 26, 2025 (after market close)Other info last updated April 2, 2025